HTFL

Heartflow, Inc. Common Stock$48.55-0.99 (-2.00%)

Prev Close$49.54·MCap$4.30B·P/E—·Vol958.4K·Yield—

▲

Buys (12M)

$1.05M

▼

Sells (12M)

$135.86M

◆

Net Activity

Net Seller

$134.81M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Heartflow, Inc. Common Stock (HTFL) has been dominated by selling, with 1 insider purchase totaling $1.05M and 26 insider sales totaling $135.86M. The most recent insider transaction was by Verghese Vikram (officer: Chief Financial Officer), who sold $1.75M worth of shares on Sep 15, 2026. Heartflow, Inc. Common Stock operates in the Healthcare sector, within the Medical - Healthcare Information Services industry, with a market cap of $4.30B.

HTFL Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 15, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	34,975	$50.08	$1.75M	184,789
Sep 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$46.78	$1.82M	325,804
Sep 10, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	6,640	$50.03	$332.2K	214,503
Sep 4, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	33,416	$49.85	$1.67M	248,683
Aug 25, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	27,230	$50.00	$1.36M	360,814
Aug 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	32,676	$45.00	$1.47M	388,044
Aug 19, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$41.23	$380.1K	86,459
Aug 18, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	15,560	$39.06	$607.8K	420,720
Aug 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.31	$638.7K	436,280
Jul 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$25.72	$237.1K	88,731
Jul 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.75	$626.1K	435,373
Jun 26, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$35.00	$1.36M	457,935
Jun 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.50	$643.0K	496,835
May 20, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$28.34	$261.3K	78,731
May 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$29.12	$657.0K	519,397
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$29.45	$58.90M2.3% OS	10,194,048
Apr 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$26.72	$602.9K	549,163
Mar 23, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	64,533	$25.69	$1.66M	78,518-45%
Mar 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	9,725	$25.00	$243.1K	571,725
Mar 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	12,837	$22.66	$290.9K	581,450
Mar 6, 2026	Cullivan Julie A	director	Sell	9,122	$25.00	$228.1K	27,291-25%
Feb 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	65,153	$24.49	$1.60M	76,034-46%
Feb 12, 2026	Rogers Campbell	Chief Medical Officer	Sell	65,153	$24.49	$1.60M	0
Feb 10, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.46	$619.6K	591,656
Feb 6, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$28.05	$56.10M2.3% OS	10,448,158
Feb 6, 2026	Cullivan Julie A	director	Sell	8,000	$27.32	$218.6K	36,413
Dec 17, 2025	Lightcap Jeffrey C	Director	Buy	40,000	$26.34	$1.05M	40,000

HTFL Insider Buying Activity

The following table shows recent insider purchases of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 17, 2025	Lightcap Jeffrey C	Director	Buy	40,000	$26.34	$1.05M	40,000

HTFL Insider Selling Activity

The following table shows recent insider sales of Heartflow, Inc. Common Stock (HTFL) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 15, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	34,975	$50.08	$1.75M	184,789
Sep 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$46.78	$1.82M	325,804
Sep 10, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	6,640	$50.03	$332.2K	214,503
Sep 4, 2026	Verghese Vikram	officer: Chief Financial Officer	Sell	33,416	$49.85	$1.67M	248,683
Aug 25, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	27,230	$50.00	$1.36M	360,814
Aug 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	32,676	$45.00	$1.47M	388,044
Aug 19, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$41.23	$380.1K	86,459
Aug 18, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	15,560	$39.06	$607.8K	420,720
Aug 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.31	$638.7K	436,280
Jul 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$25.72	$237.1K	88,731
Jul 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.75	$626.1K	435,373
Jun 26, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	38,900	$35.00	$1.36M	457,935
Jun 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$28.50	$643.0K	496,835
May 20, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	9,219	$28.34	$261.3K	78,731
May 13, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$29.12	$657.0K	519,397
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$29.45	$58.90M2.3% OS	10,194,048
Apr 14, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$26.72	$602.9K	549,163
Mar 23, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	64,533	$25.69	$1.66M	78,518-45%
Mar 20, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	9,725	$25.00	$243.1K	571,725
Mar 12, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	12,837	$22.66	$290.9K	581,450
Mar 6, 2026	Cullivan Julie A	director	Sell	9,122	$25.00	$228.1K	27,291-25%
Feb 17, 2026	Rogers Campbell	officer: Chief Medical Officer	Sell	65,153	$24.49	$1.60M	76,034-46%
Feb 12, 2026	Rogers Campbell	Chief Medical Officer	Sell	65,153	$24.49	$1.60M	0
Feb 10, 2026	Farquhar John C.M.	director, officer: Chief Executive Officer	Sell	22,562	$27.46	$619.6K	591,656
Feb 6, 2026	Bain Capital Life Sciences Investors, LLC	10 percent owner	Sell	2,000,000	$28.05	$56.10M2.3% OS	10,448,158
Feb 6, 2026	Cullivan Julie A	director	Sell	8,000	$27.32	$218.6K	36,413